Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 Outcomes of patients who received HES ≥ 1000mL or < 1000 mL

From: Large volume infusions of hydroxyethyl starch during cardiothoracic surgery may be associated with postoperative kidney injury: propensity-matched analysis

  HES ≥ 1000 mL HES < 1000 mL p value
Number of patients 179 357  
AKI incidents 57 (31.8%) 94 (26.3%) 0.22
AKI stage
1 35 (19.6%) 58 (16.2%)  
2 3 (1.7%) 17 (4.8%)  
3 19 (10.6%) 19 (5.3%)  
Peak serum creatinine (mg/dL) 1.01 (0.81–1.33) 0.94 (0.75–1.25) 0.038
RRT requirement 16 (8.9%) 14 (3.9%) 0.017
ICU length of stay (days) 4 (3–5) 3 (3–5) 0.27
28-day hospital free days (days) 10 (0–14) 12 (5–14) 0.032
Hospital mortality 13 (7.3%) 9 (2.5%) 0.017
  1. Data are expressed as medians with 25th to 75th percentiles or percentages
  2. HES hydroxyethyl starch, AKI acute kidney injury, RRT renal replacement therapy, ICU intensive care unit